OOIR: Observatory of International Research

Papers

(The TQCC of Cost Effectiveness and Resource Allocation is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Establishing a reasonable price for an orphan drug	45
Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds	31
Status and determinants of enrollment and dropout of health insurance in Nepal: an explorative study	23
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US	20
What makes inequality in the area of dental and oral health in developing countries? A scoping review	19
Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran	19
How much the Iranian government spent on disasters in the last 100 years? A critical policy analysis	18
Is bed turnover rate a good metric for hospital scale efficiency? A measure of resource utilization rate for hospitals in Southeast Nigeria	18
Determinants of catastrophic health expenditures in Iran: a systematic review and meta-analysis	16
Health systems efficiency in Eastern Mediterranean Region: a data envelopment analysis	16
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making	15
First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis	15
Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis	15
Cost-effectiveness analysis of text messaging to support health advice for smoking cessation	15
Strategies for reducing out of pocket payments in the health system: a scoping review	14
Household catastrophic health expenditure and its effective factors: a case of Iran	14
Examination on level of scale efficiency in public hospitals in Tanzania	13
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma	13
Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—2023	13
Generalised cost-effectiveness analysis of 159 health interventions for the Ethiopian essential health service package	12
Level and determinants of county health system technical efficiency in Kenya: two stage data envelopment analysis	12
Some reflections on the use of inappropriate comparators in CEA	11
Introduction of birth dose of hepatitis B virus vaccine to the immunization program in Ethiopia: an economic evaluation	11
Cost-utility analysis in chronic kidney disease patients undergoing kidney transplant; what pays? A systematic review	11
Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment	11

Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist care	11
Comparison of cost effectiveness between video-assisted thoracoscopic surgery (vats) and open lobectomy: a retrospective study	10
Hospital efficiency measurement in the west of Iran: data envelopment analysis and econometric approach	10
Cost-effectiveness of pharmacological therapies for people with Alzheimer’s disease and other dementias: a systematic review and meta-analysis	10
Predicting positive organizational behavior based on structural and psychological empowerment among nurses	10
Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy	10
Market access and value-based pricing of digital health applications in Germany	9
Cost effectiveness of outpatient lumbar discectomy	9
Assessing the efficiency of Iran health system in making progress towards universal health coverage: a comparative panel data analysis	9
Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong	8
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong	8
A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases	8
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?	8
Methodological challenges surrounding QALY estimation for paediatric economic evaluation	8
Factors affecting the technical efficiency of rural primary health care centers in Hamadan, Iran: data envelopment analysis and Tobit regression	7
Modeling the Cost-effectiveness of Esophageal Cancer Screening in China	7
Cost-effectiveness of facility-based, stand-alone and mobile-based voluntary counseling and testing for HIV in Addis Ababa, Ethiopia	7
The use of evaluation methods for the overall assessment of health policy: potential and limitations	7
Cost-effectiveness of a care manager collaborative care programme for patients with depression in primary care: 12-month economic evaluation of a pragmatic randomised controlled trial	7
The effect of different classification of hospitals on medical expenditure from perspective of classification of hospitals framework: evidence from China	7
Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey	7
Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China	7
Health technology assessment of medical devices: current landscape, challenges, and a way forward	7
Cost transferability problems in economic evaluation as a framework for an European health care and social costs database	7
Comparison of the healthcare system of Chile and Brazil: strengths, inefficiencies, and expenditures	7
Supporting a review of the benefits package of the National Health Insurance Scheme in Ghana	6
Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?	6
Neural networks and hospital length of stay: an application to support healthcare management with national benchmarks and thresholds	6
The pharmaceutical practice of mask distribution by pharmacists in Taiwan’s community pharmacies under the Mask Real-Name System, in response to the COVID-19 outbreak	6
Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan	6
The influence of medical insurance and social security cards on the floating population's settlement intention	6
Dynamic linkages among economic development, environmental pollution and human health in Chinese	6
Can integrated care improve the efficiency of hospitals? Research based on 200 Hospitals in China	6
Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care only	6
Selecting the most suitable organizational structure for hospitals: an integrated fuzzy FUCOM-MARCOS method	6
Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings	6
Cost-effectiveness of a novel smartphone application to mobilize first responders after witnessed OHCA in Belgium	6
Impact of quality certification of multidisciplinary head and neck tumor centers	5
Predictors of loss due to pharmaceutical fraud: evidence from the U.S.	5
Recommendations to improve insurance coverage for physiotherapy services in Iran: a multi criteria decision-making approach	5
The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective	5
Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries	5
A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in Egypt	5
Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact	5
Household preferences and willingness to pay for health insurance in Kampala City: a discrete choice experiment	5
What are economic costs and when should they be used in health economic studies?	5
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting	5
A systemmatic literature review on indirect costs of women with breast cancer	5
The health care sector in the economies of the European Union: an overview using an input–output framework	5
Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation	5

Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives	5
Exploring physicians and patients’ perspectives for current interventions on thyroid nodules using a MCDA method	5
A comprehensive framework for considering additional unintended consequences in economic evaluation	5
Out-of-pocket payments for treatment of COVID-19 in Iran	4
Title: the impact of a pilot integrated care model on the quality and costs of inpatient care among chinese elderly: a difference-in-difference analysis of repeated cross-sectional data	4
An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran	4
A systematic review of the budget impact analyses for antitumor drugs of lung cancer	4
Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china	4
Budget impact analysis of lens material on the posterior capsule opacification (PCO) as a complication after the cataract surgery	4
Clinical and economic benefits of image-guided system in functional endoscopicsinus surgery: a retrospective chart review study in China	4
Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review	4
Feasibility of implementing public–private partnership (PPP) in the development of hospital services and optimizing resource allocation in Iran	4
Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan	4
Risk factors associated with postoperative complications after liver cancer resection surgery in western China	4
The impact of common chronic conditions on health-related quality of life: a general population survey in Iran using EQ-5D-5L	4
Cost-effectiveness analysis of nonoperative management versus open and laparoscopic surgery for uncomplicated acute appendicitis in Colombia	4
Association between changes in economic activity and catastrophic health expenditure: findings from the Korea Health Panel Survey, 2014–2016	4
Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis	4
Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients	4
The origin of cost–benefit analysis: a comparative view of France and the United States	4
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”	4
Changes in productivity in healthcare services in the Kingdom of Saudi Arabia	4
The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission	4
Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting	4
Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial	4
The potential of real-time analytics to improve care for mechanically ventilated patients in the intensive care unit: an early economic evaluation	4
One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis	4
Total productivity change of Health Centers in Greece in 2016–2018: a Malmquist index data envelopment analysis application for the primary health system of Greece	4
Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review	4